Wells Fargo Names Steven Black Chairman With Immediate Effect, Succeeding Charles Noski

Financial services major Wells Fargo & Co. (WFC) announced Tuesday that Steven Black has been elected as chairman of Board of Directors, effective immediately.

Black succeeds Charles Noski, who has stepped down as chairman. Noski will remain as a director until he retires on September 30.

The board also appointed Wayne Hewett to serve as a member and as chair of the Governance and Nominating Committee.

Noski has served as a director since June 2019 and as chairman since March 2020. Noski previously served as chair of the board's Audit Committee and, until today, as chair of its Governance and Nominating Committee.

The newly elected chairman, who joined the board in 2020, has over 45 years of financial services experience with some of the largest financial institutions in the world. He has served as co-CEO of Bregal Investments, a private equity firm, since September 2012.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
Follow RTT